Elekta (OTCMKTS:EKTAY) Trading Down 13.2% – Here’s Why

Elekta AB (OTCMKTS:EKTAY)’s share price traded down 13.2% on Friday . The stock traded as low as $5.7530 and last traded at $5.7530. 267 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 2,419 shares. The stock had previously closed at $6.63.

Elekta Stock Down 13.2%

The company has a current ratio of 0.95, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56. The firm has a 50 day moving average price of $6.01 and a 200-day moving average price of $5.99. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of -574.73 and a beta of 1.01.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The company had revenue of $521.00 million for the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%. On average, equities analysts forecast that Elekta AB will post 0.39 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.